Browse > Article
http://dx.doi.org/10.5010/JPB.2010.37.3.313

The development of transgenic maize expressing Actinobacillus pleuropneumoniae ApxIIA gene using Agrobacterium  

Kim, Hyun-A (Department of Medicinal Plant Resources, Nambu University)
Yoo, Han-Sang (Department of Infectious Diseases, College of Veterinary, Seoul National University)
Yang, Moon-Sik (Division of Biological Science, Chonbuk National University)
Kwon, Suk-Yoon (Korea Research Institute of Bioscience and Biotechnology)
Kim, Jin-Seog (Korea Research Institute of Chemical Technology)
Choi, Pil-Son (Department of Medicinal Plant Resources, Nambu University)
Publication Information
Journal of Plant Biotechnology / v.37, no.3, 2010 , pp. 313-318 More about this Journal
Abstract
To develop edible vaccines for swine, the embryogenic calli (type II) derived from HiII genotype were inoculated with A. tumefaciens strain C58C1 containing the binary vector pMYV611, 613, 616, and V621, 622 and 623 respectively. Six of those vectors carry nptII gene which confers resistance to paromomycin and apxIIA gene producing ApxII toxin which is generated in various serum types of A. pleuropneumoniae as a target gene. The 4,120 callus clones for pMYV611, 5,959 callus clones for pMYV613, 7,581 callus clones for pMYV616, 52,329 callus clones for V621, 48,948 callus clones for V622, and 56,188 callus clones for V623 were inoculated. The frequency of positive response clone was confirmed into range of 2.3% - 4.4% for each vectors by NPTII ELISA kit assay, and the selected callus clones of them were finally 3 callus clones from pMYV611 (0.07%), 4 callus clones from pMYV613 (0.07%), 2 callus clones from pMYV616 (0.03%), 51 callus clones from V621 (0.1%), 72 callus clones from V622 (0.15%), and 102 callus clones from V623 (0.18%) respectively. From the selected callus clones of each binary vector, the integration of the apxIIA gene into maize genome was detected from 2 plants of pMYV613 and 2 plants of V623 by Southern blot analysis.
Keywords
A. pleuropneumoniae; apxIIA gene; edible vaccine; paromomycin; type II embryogenic callus; transgenic maize;
Citations & Related Records
Times Cited By KSCI : 1  (Citation Analysis)
연도 인용수 순위
1 Murashige T, Skoog F (1962) A revised medium for rapid growth and bioassay with tobacco tissue cultures. Physiol Plant 15:473-497   DOI
2 Richter LJ, Thanavala Y, Arntzen CJ, Mason HS (2000) Production of hepatitis B surface antigen in transgenic plants for oral immunization. Nature Biotechnol 18:1167-1171   DOI
3 Roa-Rodriguez C, Nottenburg (1999) NptIIgene in combination with paromomycin as a selective agent. Patent EP 927765A1
4 Thanavala Y, Yang YF, Lyons P, Mason HS, Arntzen CJ (1995) Immunogenicity of transgenic plant-derived hepatitis B surface antigen. Proc Natl Acad Sci USA 92:3358-3361   DOI
5 Curtiss RI, Cardineau CA (1990) Oral immunisation by transgenic plants, World Patent Application. WO 90/02484
6 Kim HA, Utomo SD, Kwon SY, Min SR, Kim JS, Yoo HS, Choi PS (2009) The development of herbicide-resistant maize: stable Agrobacterium-mediated transformation of maize using explants of type II embryogenic calli. Plant Biotechnol Rep 3:277-283   DOI   ScienceOn
7 Curtis IS, Power JB, Hedden P, Phillips A, Lowe KC, Ward DA, Davey MR (2000) Transformation and characterization of transgenic plants of Solanum dulcamara L. –Incidence of transgene silencing. Ann Bot 86:63-71   DOI
8 Dellaporta SL, Wood J, Hicks JB (1983) Maize DNA miniprep. In: Malmberg R, Messing J, Sussex (eds), Molecular Biology of Plants: A laboratory Course Manual, Cold Spring Harbor Laboratory, Cold Spring Harbor, New York. pp 36-37
9 Haq T, Mason HS, Clements JD, Arntzen CJ (1995) Oral immunization with a recombinant bacterial antigen produced in transgenic plants. Science 268:714-716   DOI
10 Kong Q, Richer L, Yang YF, Arntzen CJ, Mason HS, Thanavala Y (2001) Oral immunization with hepatitis B surface antigen expressed in transgenic plants. Proc Natl Acad Sci USA 93:5335-5340
11 Mason HS, Dominic Mam-Kit L, Arntzen CJ (1992) Expression of hepatitis B surface antigen in transgenic plants. Proc Natl Acad Sci USA 89:11445-11749
12 Mason HS, Ball JM, Shi JJ, Jiang X, Estes MK, Arntzen CJ (1996) Expression of norwalk virus capsid protein in transgenic tobacco and potato and its oral immunogenicity in mice. Proc Natl Acad Sci USA 93:5335-5340   DOI
13 Mason HS, Haq TA, Clements JD, Arntzen CJ (1998) Edible vaccine protects mice against Escherichia coliheat-labile enterotoxin(LT): potatoes expressing a synthetic LT-B gene. Vaccine 16:1336-1343   DOI
14 Cho MA, Park YO, Kim JS, Park KJ, Min HK, Liu JR, Clemente T, Choi PS (2005) Production of transgenic maize (Zea mays L.) using Agrobacterium tumefaciens-mediated transformation. Kor Plant Biotechnol 32:91-95   과학기술학회마을   DOI
15 Armstrong CL, Green CE, Phillips RL (1991) Development and availability of germplasm with high Type II culture formation response. Maize Genetics Cooperative Newsletter 65:92-93
16 Chikwamba R, Cunnick J, Hathaway D, McMurray J, Mason HS, Wang K (2002) A functional antigen in a practical crop: LT-B producing maize protects mice against Escherichia coli heat labile enterotoxin (LT) and cholera toxin (CT). Trans Res 11:479-493   DOI